NUVB - Nuvation Bio Inc. -  [ ]

Ticker Details
Nuvation Bio Inc.
IPO Date: August 24, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.61B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.14 | 3.27%
Avg Daily Range (30 D): $0.13 | 2.77%
Avg Daily Range (90 D): $0.18 | 2.79%
Institutional Daily Volume
Avg Daily Volume: 1.83M
Avg Daily Volume (30 D): 3.85M
Avg Daily Volume (90 D): 4.6M
Trade Size
Avg Trade Size (Sh.): 204
Avg Trade Size (Sh.) (30 D): 162
Avg Trade Size (Sh.) (90 D): 169
Institutional Trades
Total Institutional Trades: 775
Avg Institutional Trade: $2.24M
Avg Institutional Trade (30 D): $1.89M
Avg Institutional Trade (90 D): $2.3M
Avg Institutional Trade Volume: .47M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.74M
Avg Closing Trade (30 D): $2.19M
Avg Closing Trade (90 D): $2.99M
Avg Closing Volume: 529.36K
 
News
Mar 21, 2026 @ 9:15 PM
NUVB Investors Have Opportunity to Join Nuvation B...
Source: Schall Law Firm
Mar 10, 2026 @ 7:52 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investo...
Source: Pomerantz Llp
Feb 17, 2026 @ 4:17 PM
New Treatment Modalities Are Reaching Cancers That...
Source: Prnewswire
Nov 3, 2025 @ 11:10 AM
Nuvation Bio Chief Scientist Sells 100,000 Shares ...
Source: Jonathan Ponciano
Apr 3, 2024 @ 9:36 AM
Intel, XPeng And Other Big Stocks Moving Lower In ...
Source: Avi Kapoor
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-.6 $-.11 $-.6
Diluted EPS $-.6 $-.11 $-.6
Revenue $62.9M $41.87M $62.9M
Gross Profit
Net Income / Loss $-204.63M $-36.59M $-204.63M
Operating Income / Loss $-213.06M $-34.04M $-213.06M
Cost of Revenue
Net Cash Flow $128.36M $65.19M $128.36M
PE Ratio